The influence of drug dosage on Helicobacter pylori eradication: A cost-effectiveness analysis

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 246-257

  Treiber, Gerhard ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; BISMUTH SALICYLATE; CIMETIDINE; CLARITHROMYCIN; FAMOTIDINE; IMIDAZOLE DERIVATIVE; LANSOPRAZOLE; OMEPRAZOLE; OXYTETRACYCLINE; RANITIDINE; TETRACYCLINE; TINIDAZOLE;

ARTICLE; CHRONIC GASTRITIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ACID SECRETION; ULCER HEALING;

AMOXICILLIN; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMIDAZOLES; OMEPRAZOLE; PENICILLINS; REGRESSION ANALYSIS; STOMACH ULCER; TETRACYCLINE; TIME FACTORS;

EID: 0030064351     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (227)

1. Labenz J, Börsch G. Therapie der Helicobacter-pylori-Infektion. Dtsch Med Wochenschr 1994;119:669-72.
2. Berstad K, Berstad A. Helicobacter pylori infection in peptic ulcer disease. Scand J Gastroenterol 1993;28:561-7.
3. Bell GD, Powell KU. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993;28(suppl 196):7-11.
4. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
5. Rokkas T, Mavrogeorgis A, Rallis E, et al. Helicobacter pylori eradication reduces the possibility of rebleeding in peptic ulcer disease. Gut 1993;34(suppl):OI/4 188 (abstract).
6. Labenz J, Börsch G. Helicobacter pylori eradication prevents peptic ulcer bleeding relapse. Acta Gastroenterol Belg 1993;56(suppl):138 (abstract).
7. O'Connor HJ, Kanduru C, Cunnane K. Effect of H. pylori eradication on peptic ulcer healing. Acta Gastroenterol Belg 1993;56(suppl):143 (abstract).
8. Labenz J, Börsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
9. El-Omar E, Penman I, Dorrian CA, et al. Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two-thirds in patients with duodenal ulcer. Gut 1993;34:1060-5.
10. Chiba N, Rao BV, Rademaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
11. Wagner S, Gebel M, Manns M. Therapie der Helicobacter pylori-Infektion: Aktueller Stand. Z Gastroenterol 1993;31:459-63.
12. Noach LA, Tytgat GNJ. Treatment of Helicobacter pylori infection: An evaluation of various therapeutic trials and review of the literature. In: Helicobacter pylori infection: Aspects of pathogenesis and therapy, chapter VI. Amsterdam, 1993:83-127.
13. Patchett S, Beattie S, Leen E, et al. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. Br Med J 1991;303:1238-40.
14. Rauws EAJ, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988;94:33-40.
15. O'Riordan T, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 31:999-1002.
16. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
17. Lambert JR, Lin SK, Schembri M, et al. Helicobacter pylori therapy: Randomized study of denol/antibiotic combinations. Rev Esp Enferm Dig 1990;78(suppl):115-6 (abstract).
18. Treiber G, Gladziwa U, Ittel TH, et al. TDB: Absorption and urinary excretion of bismuth in patients with normal and impaired renal function. Aliment Pharmacol Ther 1991;5:491-502.
19. Tytgat GNJ, Rauws EAJ, Langenberg W, et al. Long-term follow-up of C. pylori-associated gastritis after treatment with colloidal bismuth subnitrate and/or amoxicillin. Gastroenterology 1988;94(5, part 2): A469 (abstract).
20. Treiber G, Walker S, Fritz P, et al. Two different therapeutic regimes to attempt Helicobacter pylori eradication. Acta Gastroenterol Belg 1993;56(suppl):146 (abstract).
21. Lambert JR, Borromeo M, Eaves ER, et al. Efficacy of different dosage regimens of bismuth in eradicating Campylobacter pylori. Gastroenterology 1990;98(5, part 2):A248 (abstract).
22. Mantzaris GJ, Hatzis A, Kontoyiannis P, et al. A prospective study of Helicobacter pylori infection treatment in resistant duodenal ulcers. Gastroenterology 1992;102(suppl):A118 (abstract).
23. Sobala GM, Lynch DAF, Gallacher B, et al. Eradication of Helicobacter pylori prevents duodenal ulcer recurrence. Ir J Med Sci 1992; 161(suppl 10):89 (abstract T7).
24. Xia HX, Daw MA, Saint S, et al. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993;5:141-4.
25. Stanescu-Siegmund A, Gabard B, Dragici A, et al. Bismuth citrate/ amoxicillin: A new galenic formulation for Helicobacter pylori eradication. Acta Gastroenterol Belg 1993;56(suppl):A145.
26. Goh KL, Wong NW, Parasakthi N, et al. Efficacy of various treatment regimens in the eradication of Helicobacter pylori amongst Southeast Asian patients. Acta Gastroenterol Belg 1993;56(suppl):A 135.
27. Bierti L, Bolis EG, DiBattista R, et al. Tripotassium dicitrato bismutate and ranitidine in preventing duodenal ulcer relapse. Ir J Med Sci 1992;161(suppl 10):91 (abstract T15)
28. Oddsson E, Gudjonsson H, Theodors A, et al. De-nol or de-nol + metronidazol in the treatment of Helicobacter pylori positive patients with non-ulcer dyspepsia: Symptomatic response and eradication rate. Gastroenterology 1992;102(suppl):A137 (abstract).
29. Börsch G, Mai U, Müller KM, et al. Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease. Scand J Gastroenterol 1988;84:643-6.
30. Mannes GA, Bayerdörffer E, Hochter W, et al. Relapse rate of Helicobacter pylori-positive duodenal ulcers following antibacterial therapy. WCG Sydney 1990;955 (abstract).
31. Wagner S, Varrentrapp M, Haruma K, et al. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection. Z Gastroenterol 1991;29:595-8.
32. Takats A, Penyige J, Ovari Z, et al. Role of various antibiotics in triple therapy in the eradication of Helicobacter pylori. Acta Gastroenterol Belg 1993;56(suppl):A146.
33. Mannes GA, Bayerdörffer E, Höchter W, et al. Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trial. Eur J Gastroenterol Hepatol 1993;5:145-53.
34. Westblom TU, Madan E, Subik MA, et al. Double-blind trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Scand J Gastroenterol 1992;27:249-52.
35. Wagner S, Freise J, Bär W, et al. Epidemiologie und Therapie der Campylobacter pylori Infektion. Dtsch Med Wochenschr 1989;114: 407-13.
36. Unge P, Gad A, Gnarpe H, et al. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? Scand J Gastroenterol 1989;24(suppl 167):49-54.
37. Glupczynski Y, Burette A, Labbe M, et al. Campylobacter pylori-associated gastritis: A double blind placebo-controlled trial with amoxicillin. Am J Gastroenterol 1988;83:365-72.
38. Boixeda D, Ballestero S, Canton R, et al. Amoxicillin/clavanulate capsules vs amoxicillin/clavanulate suspension treatment in the eradication of Helicobacter pylori. Ir J Med Sci 1992;161 (suppl 10):2 (abstract W1.6).
39. Graham DY, Opekun AR, Klein PD. Clarithromicin for the eradication of Helicobacter pylori. J Clin Gastroenterol 1993;16:292-4.
40. Peterson WL, Graham DY, Marshall B, et al. Clarithromicin as monotherapy for eradication of Helicobacter pylori: A randomized double-blind trial. Am J Gastroenterol 1993;88:1860-4.
41. Bayerdörffer E, Mannes GA, Sommer A, et al. Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxicillin. Scand J Gastroenterol 1993;28(suppl 196): 19-25.
42. Rune S, Justesen T, Moller-Hansen J, et al. Prevention of duodenal ulcer recurrence with penicillin. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1993;28:438-42.
43. Sung JJY, Chung SCS, Ling TKW, et al. One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori. Am J Gastroenterol 1994;89:199-202.
44. Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325-31.
45. Louw JA, Zak J, Jaskiewicz K, et al. Omeprazole may clear but does not eradicate H. pylori. Eur J Gastroenterol Hepatol 1992;4:481-5.
46. Labenz J, Gyenes E, Rühl GH, et al. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993;88:491-95.
47. Fiocca R, Villiani L, Luinetti O, et al. Helicobacter pylori eradication and sequential clearance of inflammation in duodenal ulcer patients treated with omeprazole and antibiotics. Ir J Med Sci 1992;161(suppl 10):93 (abstract T23).
48. Bayerdörffer E, Miehlke S, Mannes GA, et al. Helicobacter pylori eradication in duodenal ulcer patients with combined high dose omeprazole (120 mg) and amoxicillin treatment. Acta Gastroenterol Belg 1993;56(suppl):A130.
49. Greaves RG, Cayla R, Mendelson MG, et al. Omeprazole vs clarithromicin and omeprazole for eradication of Helicobacter pylori. Acta Gastroenterol Belg 1993;56(suppl):A136.
50. Korwin JD de, Joubert M, Bazin N, et al. Lansoprazole versus lansoprazole plus antibiotics in the treatment of Helicobacter pylori gastric infection. Gastroenterology 1993;104(suppl):A67 (abstract).
51. Hosking SW, Ling TK, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
52. Weil J, Bell GD, Powell K, et al. Omeprazole and Helicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991;5:309-13.
53. Daw MA, Deegan P, Beattie S, et al. Suppression of Helicobacter pylori during the clinical use of omeprazole. Gut 1990;31(suppl):38 (abstract).
54. Rauws EAJ, Langenberg W, Bosma A, et al. Lack of eradication of Helicobacter pylori after omeprazole. Lancet 1991;337:1093 (letter).
55. Bayerdörffer E, Mannes GA, Höchter W, et al. Antibacterial treatment of gastric ulcers: German gastric ulcer study. Gastroenterology 1993;104(suppl):A40 (abstract).
56. Kuipers EJ, Klinkenberg-Knol EC, Festen HPM, et al. Effects of long-term omeprazole use on Helicobacter pylori status. Gastroenterology 1993;104(suppl):A124 (abstract).
57. Marshall BJ, Dye KR, Plankey M, et al. Eradication of Campylobacter pylori infection with bismuth subsalicylate and antibiotic combinations. Am J Gastroenterol 1988;83:A74 (abstract).
58. Mangiameli A, Catalano F, Monello S, et al. Colloidal bismuth and amoxicillin acute treatment and 4-week follow up of Helicobacter pylori-positive non-ulcer dyspepsia. Ital J Gastroenterol.
59. Munoz N, Buiatti E, Vivas J, et al. Difficulty in eradicating Helicobacter pylori in a high risk population for stomach cancer in Venezuela. Ir J Med Sci 1992;161(suppl 10):6 (abstract W2.9).
60. Sabbatini F, D'Arienzo A, Piai G, et al. Influence of blood group and secretor status on Campylobacter pylori infection. Gastroenterology 1989;96(suppl):A433 (abstract)
61. DeKoster E, Nyst JF, DePrez C, et al. Treatment of Helicobacter pylori: One week colloidal bismuth subcitrate + tinidazole. WCG Sydney 1990; PD 93 (abstract).
62. Bell GD, Weil J, Powell K, et al. Helicobacter pylori treated with combinations of tripotassium dicitrato and metronidazole: Efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991;3: 819-22.
63. Weil J, Bell GD, Jones PH, et al. Eradication of Campylobacter pylori: Are we being misled? Lancet 1988;2:1245 (letter).
64. Vaira D, Miglioloi M, Menegatti M, et al. Treatment of symptom-free Helicobacter pylori-positive subjects. Eur J Gastroenterol Hepatol 1993;5(suppl 2):S96-8.
65. Bologna E, Stroppiana M, Peyre S, et al. Helicobacter pylori treatment: Comparison of four weeks versus ten day CBS and metronidazole course. Ir J Med Sci 1992;161(suppl 10):92 (abstract T18).
66. Boero M, Ponzetto A, Rosina F, et al. Rate of eradication with different drug schedules. Klin Wochenschr 1989;67(suppl 18):5-6 (abstract).
67. Peyre S, Bologna E, Stroppiana M, et al. Eradication rate of Helicobacter pylori with 4 different regimens. Rev Esp Enferm Dig 1990; 78(suppl 1):107-8 (abstract).
68. Burette A, Glupczynski Y, DePrez C, et al. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:817-23.
69. Burette A, Glupczynski Y, DePrez C, et al. Two week combination therapies with tetracycline are less effective than similar regimens with amoxicillin. Acta Gastroenterol Belg 1993;56(suppl):A131.
70. Wagner S, Gebel M, Haruma K, et al. Bismuth subsalicylate in the treatment of H2-blocker resistant duodenal ulcers: Role of Helicobacter pylori. Gut 1992;33:179-83.
71. Bell GD, Powell K, Weil J, et al. Experience with omeprazole in combination with either amoxicillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3:923-6.
72. Logan RPH, Greaves RR, Gummett PA, et al. The in vivo effect of ranitidine bismuth citrate on HP. Ir J Med Sci 1992;161(suppl 10):94 (abstract T24).
73. Ferrini G, Larcinese G, Semperlotti N. Omeprazole and clarithromicin combined treatment in the cases of duodenal ulcer associated with Helicobacter pylori. Ir J Med Sci 1992;161(suppl 10):99 (abstract T43).
74. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35:323-6.
75. Neri M, Susi D, di Iorio P, et al. Eradication of Helicobacter pylori and improvement of HP related gastritis after combined treatments with omeprazole, bismuth and clarithromicin. Acta Gastroenterol Belg 1993;56(suppl):A142.
76. Labenz J, Stolte M, Domian C, et al. Omeprazole plus amoxicillin or clarithromicin for eradication of HP in DU disease. Acta Gastroenterol Belg 1993;56(suppl):A139.
77. Logan RPH, Gummet PA, Thomas P, et al. The dose and frequency of omeprazole influence the eradication rate of dual therapy. Acta Gastroenterol Belg 1993;56(suppl):A140.
78. Collins R, Beattie S, Xia HX, et al. Short report: High-dose omeprazole and amoxicillin in the treatment of Helicobacter pylori-associated duodenal ulcer. Aliment Pharmacol Ther 1993;7:313-5.
79. Adamek RJ, Wegener M, Freitag M, et al. Medium term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994;89:39-42.
80. DeKoster E, Nyst JF, Deprez C, et al. HP treatment: Disappointing results with amoxycillin plus omeprazole. Gastroenterology 1992; 102(suppl):A58 (abstract).
81. Labenz J, Gyenes E, Rühl GH, et al. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: A prospective, randomized, and controlled study. Gut 1993;34:1167-70.
82. Logan RPH, Rubio MA, Gummet PA, et al. Omeprazole and amoxicillin suspension for Helicobacter pylori. Ir J Med Sci 1992; 161(suppl 10):16 (abstract W7.6).
83. Adamek RJ, Freitag M, Wegener M, et al. Results of short term omeprazole oral and amoxicillin intravenous Helicobacter pylori eradication therapies. Acta Gastroenterol Belg 1993;56(suppl):A128.
84. Lamouliatte H deMascarel A, Megraud F, et al. Omeprazole improves amoxicillin therapy towards Helicobacter pylori associated chronic gastritis. Gastroenterology 1990;98 (suppl):A75 (abstract).
85. Mannes GA, Bayerdörffer E, Hele C, et al. An increasing dose of omeprazole combined with amoxicillin increases the eradication rate of Helicobacter pylori. Gastroenterology 1993;104(suppl):A140 (abstract).
86. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: Efficacy and side effect profile of a combination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
87. Bell GD, Powell KU, Burridge SM, et all. Short report: Omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1992; 6:751-8.
88. Burette A, Glupczynski Y, DePrez C, et al. Omeprazole plus amoxicillin regimens for eradication of Helicobacter pylori. Acta Gastroenterol Belg 1993;56(suppl):A131.
89. Labenz J, Rühl GH, Bertrams J, et al. Efficiency of three amoxicillin/ omeprazole schedules for eradication of HP in DU disease. Acta Gastroenterol Belg 1993;56(suppl):A138.
90. Krausse R, Müller G, Ullmann U. Effect of a short term therapy with omeprazole and amoxicillin on H. pylori eradication: Ulcer healing and relapse in patients with peptic ulcer. Acta Gastroenterol Belg 1993;56(suppl):A137.
91. Labenz J, Rühl GH, Bertrams J, et al. Efficiency of two amoxicillin/ omeprazole schedules for eradication of HP in GU disease. Acta Gastroenterol Belg 1993;56(suppl):A56.
92. Adamek RJ; Wegener M, Birkholz S, et al. Modified combined omeprazole/amoxicillin therapy for Helicobacter pylori eradication: A pilot study. Leber-Magen-Darm 1992;6:222-4.
93. Wagner S, Bleck J, Gebel M, et al. What treatment is best for gastric Helicobacter pylori infection? Ir J Med Sci 1992;161(suppl 10):16 (abstract W7.5).
94. Bianchi Porro G, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori-positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut 1993;34:466-9.
95. Börsch G, Mai U, Opferkuch W. Short and medium term results of oral triple therapy to eradicate Campylobacter pylori. Gastroenterology 1989;96(suppl):A53 (abstract).
96. Logan RPH, Gummett PA, Misiewicz JJ, et al. One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut 1994;35:15-8.
97. Logan RPH, Gummett PA, Misiewicz JJ, et al. One week eradication regimen for Helicobacter pylori. Lancet 1991;338:1249-52.
98. Catalano F, Rizzo G, Ayoubi-Khajekini MT, et al. Helicobacter pylori-positive dyspepsia: Results of four days treatment. Ir J Med Sci 1992;161(suppl 10):94 (abstract T26).
99. Chen TS, Tsay SH, Chang FY, et al. Eradication of Helicobacter pylori and duodenal ulcer relapse: A comparison of one-week regimen to two-week regimen. Acta Gastroenterol Belg 1993;56(suppl): A132.
100. Fatela N, Cristino JM, Monteiro L, et al. Difficulty in eradicating Helicobacter pylori with "triple therapy." Acta Gastroenterol Belg 1993;56(suppl):A134.
101. Poniewierka E, Budnik TM, Gosciniak G. Results of treatment of duodenal ulcer disease coexisting with infection of Helicobacter pylori. Acta Gastroenterol Belg 1993;56(suppl):A143.
102. Tepes B, Kavcic B. Our experience in eradication of Helicobacter pylori in patients with chronic ulcer disease and preliminary results of more than one year follow-up. Acta Gastroenterol Belg 1993;56(suppl):A154.
103. Franco JMM, Coelho LGV, Castro FJ, et al. Helicobacter pylori treatment: Sydney regimen vs metronidazole-free regimen. Acta Gastroenterol Belg 1993;56(suppl):A134.
104. DeBona M, Bellumat A, Doglioni C, et al. Decrease in gastrin, pepsinogen A and C basal serum levels after oral triple therapy: A marker for Helicobacter pylori eradication? Acta Gastroenterol Belg 1993;56(suppl):A132.
105. Grigoriev PY, Yakovenko AV, Yakovenko EP. Efficacy of three type regimens of triple therapy with De-No1 in treatment of duodenal ulcer disease. Acta Gastroenterol Belg 1993;56(suppl):A67.
106. McColl KEL, Fullarton GM, Chittajalu R, et al. Plasma gastrin, daytime intragastric pH and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991;26:339-46.
107. Logan RPH, Gummett PA, Walker MM, et al. A three-day eradication regimen for Helicobacter pylori. Ital J Gastroenterol 1991; 23(suppl 2):111 (abstract).
108. Pinero R, Pacheco M, Poleo J, et al. Triple therapy vs omeprazole in Helicobacter pylori duodenal ulcer patients. Randomized single blind trial. Gastroenterology 1993;104(suppl):A171 (abstract).
109. Seppälä K, Färkkilä M, Nuutinen H, et al. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol 1992;27:973-6.
110. George LG, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990;153:145-9.
111. Borody T, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151:431-5.
112. Truesdale RA, Chamberlain CE, Martin DF, et al. Long-term follow-up and antibody response to treatment of patients with Helicobacter pylori. Gastroenterology 1990;98(5, part 2):A140 (abstract).
113. Thijs JC, VanZwet A, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-8.
114. Massarrat S, Dehbashi N, Salari S, et al. Two-week bismuth, tetracyclin, metronidazole (BTM) versus four-week ranitidine in treatment of duodenal ulcer (DU) and its recurrence. Gastroenterology 1992;102(suppl):A119 (abstract).
115. Bell GD, Powell K, Burridge SM, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.
116. Johnston BT, Collins JSA, Sloan JM, et al. Comparison of 3, 5, and 7 day triple therapy for H. pylori eradication. Acta Gastroenterol Belg 1993;56(suppl):A137.
117. Lian JX, Carrick J, Lee A, et al. What is the role of metronidazole resistance in the eradication of Helicobacter pylori? Acta Gastroenterol Belg 1993;56(suppl):A126.
118. Cutler AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993;88:1359-61.
119. Louw JA, Zak J, Lucke W, et al. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol 1992;191:28-31.
120. McNulty CAM, Eyre-Brook IA, Uff IS, et al. Triple therapy is not always 95% effective. In: The Vth International Workshop on Campylobacter infections. Puerta Vallarta, Mexico, February 1989.
121. Borody TJ, George LL, Brandi S, et al. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992;27:281-4.
122. Patchett S, Beattie S, Keane C, et al. Short report: Short-term triple therapy for Helicobacter pylori-associated duodenal ulcer disease. Aliment Pharmacol Ther 1992;6:113-7.
123. Radionoff P, Hyland L, Ostapowicz N, et al. Triple therapy for Helicobacter pylori eradication - 1, 2, or 4 weeks? The World Congresses of Gastroenterology, 1990, Sydney, Australia.
124. Labenz J, Gyenes E, Rühl GH, et al. Efficiency of oral triple therapy (BSS/metronidazole/tetracycline) to eradicate HP in DU disease. Ir J Med Sci 1992;161(suppl 10):90 (abstract T11).
125. DeBongnie JC, Burette A, Donnay M, et al. Gastric ulcer: Does Helicobacter pylori make it different? Acta Gastroenterol Belg 1993; 56(suppl):A55.
126. Balatsos V, Delis V, Skandalis N, et al. Triple therapy after duodenal ulcer healing with omeprazole or ranitidine eradicates Helicobacter pylori and prevents ulcer relapses: Preliminary results of a year follow up study. Gastroenterology 1993;104(suppl):A37 (abstract).
127. Hailstone AE, Martinez VA, Davis UC. Helicobacter pylori gastritis and response to treatment. Gastroenterology 1993;104(suppl):A93 (abstract).
128. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 1994;343:508-10.
129. Suriani R, Pallante C, Mazzuco D, et al. Effects of triple antibiotic therapy on gastrin serum in duodenal ulcer H. pylori-positive patients. Acta Gastroenterol Belg 1993;56(suppl):A145.
130. Logan RPH, Gummett PA, Rubio MA, et al. A one week oxytetracycline-based triple therapy for Helicobacter pylori. Ir J Med Sci 1992;161(suppl 10):6 (abstract W2.7).
131. Wyeth JW, Kallis YN, Sercombe JC, et al. Efficacy of Helicobacter pylori eradication therapy in clinical practice. Acta Gastroenterol Belg 1993;56(suppl):A149.
132. Lynch DAF, Sobala GM, Gallacher B, et al. Effectiveness of a five times daily triple therapy regime for eradicating Helicobacter pylori. Ir J Med Sci 1992;161(suppl 10):92 (abstract T16)
133. McCarthy CJ, Collins R, Beattie S, et al. Short report: Treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics. Aliment Pharmacol Ther 1993;7:463-6.
134. Lamouliatte H, Bernard PH, Cayla R, et al. Controlled study of omeprazole-amoxicillin-tinidazole vs ranitidin-amoxicillin-tinidazole in Helicobacter pylori-associated duodenal ulcers (DU). Final and long-term results. Gastroenterology 1992;102(suppl):A107 (abstract).
135. DeKoster E, Nyst JF, Deprez C, et al. Helicobacter pylori therapy: One shot versus one week. Gastroenterology 1992;102(suppl):A59 (abstract).
136. Hirschl AM, Hentschel E, Berger J, et al. Treatment of Helicobacter pylori infections with amoxicillin plus metronidazole: Bacteriological, serological and histological results. Eur J Gastroenterol Hepatol 1991;3:3-7.
137. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
138. Burette A, Glupczynski Y, DePrez C, et al. Lansoprazole plus roxithromicin and metronidazole for eradication of HP: Results of a single-blind pilot study. Acta Gastroenterol Belg 1993;56(suppl): A131.
139. Burette A, Glupczynski Y, DePrez C, et al. Omeprazole plus roxithromicin and metronidazole for eradication of Helicobacter pylori: Results of a single blind pilot study. Acta Gastroenterol Belg 1993; 56(suppl):A135.
140. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori. Acta Gastroenterol Belg 1993;56(suppl):A130.
141. DeKoster E, Deprez C. Cimetidine and amoxicillin and metronidazole in Helicobacter pylori-associated relapsing duodenal ulcer: A preliminary report. Acta Gastroenterol Belg 1993;56(suppl):A133.
142. Maieron R, Avellini C, Rizzi C, et al. Effectiveness of therapy with omeprazole and antibiotics in colloidal bismuth subcitrate non-responder Helicobacter-correlated chronic gastritis. Acta Gastroenterol Belg 1993;56(suppl):A141.
143. Sobhani I, Chastang C, DeKorwin JD, et al. Cure of duodenal ulcer: eradication of Helicobacter pylori versus maintenance of healing. results of a double blind randomized trial. Acta Gastroenterol Belg 1993;56(suppl):A145.
144. Blanco M, Alcalde M, Pajares JM. Relationship between eradication of Helicobacter pylori and duodenal ulcer relapse after three different therapies: Long term follow up. Gastroenterology 1992;102(suppl): A43 (abstract).
145. Pinero R, Poleo J, Urrestarazu M, et al. Duodenal ulcer recurrence after treatment of Helicobacter pylori. Double blind, randomized, placebo controlled trial. Two year follow up. Gastroenterology 1993; 104(suppl):A171 (abstract).
146. Graham DY, Lew GM, Ramirez FC, et al. Short report: A non-metronidazole triple therapy for eradication of Helicobacter pylori infection - tetracycline, amoxicillin, bismuth. Aliment Pharmacol Ther 1993;7:111-3.
147. Tucci A, Corinaldesi R, Stanghellini V, et al. One day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci 1993;38: 1670-73.
148. Logan RPH, Gummett PA, Misiewicz JJ, et al. Two-week eradication regimen for metronidazole resistant Helicobacter pylori. Aliment Pharmacol Ther 1993;7:149-53.
149. DeKoster E, Nyst JF, Deprez C, et al. Helicobacter pylori treatment: Double versus triple therapy: Who needs bismuth? Gastroenterology 1992;102(suppl):A58 (abstract).
150. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Intern Med 1992;116:705-8.
151. Forte GB, Bottiglieri ME, Durasco R, et al. Effect of combined therapy on duodenal ulcer associated with Helicobacter pylori infection. Ir J Med Sci 1992;161(suppl 10):95 (abstract T29).
152. Seppälä K, Sipponen P, Färkkilä M, et al. Quadruple therapy eradicates nitroimidazole resistant H. pylori. Acta Gastroenterol Belg 1993;56(suppl):A66.
153. Coelho LGV, Passos MCF, Chausson Y, et al. One week US$ 12.00 therapy heals duodenal ulcer and eradicates Helicobacter pylori. Ir J Med Sci 1992;161(suppl 10):3 (abstract W1.10).
154. Macor C, DaBroi GL, Avellini C. Results of Helicobacter pylori eradication therapy in duodenal ulcer and ulcer like dyspepsia. Ir J Med Sci 1992;161(suppl 10):25 (abstract W11.1).
155. Borody TJ, Brandi S, Andrews P, et al. Helicobacter pylori eradication failure: Further treatment possibilities. Gastroenterology 1993; 104(suppl):A43 (abstract).
156. Borody TJ, Brandl S, Andrews P, et al. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-8.
157. Borody TJ, Andrews P, Brandl S, et al. Helicobacter pylori eradication, side effects, compliance: 14 day vs 12 day triple therapy. Gastroenterology 1994;106(suppl):A44 (abstract).
158. Graham DY, Ramirez FC, Lew GM, et al. Tetracycline, clarithromicin, bismuth: A new effective triple therapy for Helicobacter pylori eradication. Am J Gastroenterol 1994;89:1203-5.
159. Corinaldesi R, Tucci A, Stanghellini V, et al. Antimicrobial susceptibility of Helicobacter before and after therapy. Acta Gastroenterol Belg 1993;56(suppl):49 (abstract IM16).
160. Graham DY, Lew GM, Malaty HM. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
161. Goodwin CS, Marshall BJ, Blincow ED, et al. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies. J Clin Pathol 1988;41:207-10.
162. Al-Assi MT, Genta RM, Graham DY. Omeprazole and amoxicillin eradicate Helicobacter pylori infection: What about omeprazole and tetracycline? Am J Gastroenterol 1994;89:A128. 12851404
163. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short term, low dose triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1364 (abstract 317).
164. Bazzoli F, Gullini S, Zagari RM, et al. Effect of omeprazole and clarithromicin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. Am J Gastroenterol 1994;89:1364 (abstract 316).
165. Jaup BH, Norrby A. Low dose short term triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1400 (abstract 461).
166. Labenz J, Rühl GH, Stolte M, et al. Efficacy of low-dose one-week triple therapy to cure Helicobacter pylori infection. Am J Gastroenterol 1994;89:1376 (abstract 364).
167. Chiba N. Low dose omeprazole + clarithromicin ± metronidazole in the eradication of Helicobacter pylori: Interim results. Am J Gastroenterol 1994;89:1367 (abstract 328).
168. Adamek RJ, Freitag M, Opferkuch W, et al. Intravenous omeprazole/ amoxicillin combination therapy in patients with Helicobacter pylori-positive acute peptic ulcer bleeding. Am J Gastroenterol 1994;89: 1361 (abstract 306).
169. Al-Assi MT, Karttunen T, Genta RM, et al. Which is important for omeprazole anti microbial therapies: pH or antimicrobial activity? Comparison of amoxicillin and omeprazole and high dose ranitidine plus sodium bicarbonate. Am J Gastroenterol 1994;89:1362 (abstract 310).
170. Al-Assi MT, Karttunen T, Genta RM, et al. Azithromicin triple therapy for Helicobacter pylori infection: Azithromicin, tetracyclin, and bismuth. Am J Gastroenterol 1994;89:1362 (abstract 309).
171. Bayerdörffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole (120 mg) + amoxicillin for Helicobacter pylori eradication in duodenal ulcer patients. Am J Gastroenterol 1994;89:1364 (abstract 315).
172. Burette A, Glupczynski Y, Deprez C, et al. Two-week omeprazole plus amoxicillin regimens for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1365 (abstract 322).
173. Carrick J, Lian JX, Daskalopoulos G. Effectiveness of two alternative second line therapies for Helicobacter pylori eradication following failure of standard triple therapy. Am J Gastroenterol 1994;89:1366 (abstract 325).
174. Cayla R, Zerbib F, De Mascarel A, et al. Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for Helicobacter pylori eradication: Results of a randomised controlled trial among 100 patients. Am J Gastroenterol 1994;89:1366 (abstract 326).
175. Cayla R, Zerbib F, De Mascarel A, et al. High dose of lansoprazole in combination with amoxicillin and clarithromicin twice daily for Helicobacter pylori eradication: Results of a pilot study. Am J Gastroenterol 1994;89:1367 (abstract 327).
176. DalBo N, Ferrana M, Salandin S, et al. Comparison of two different triple therapies with clarithromicin for Helicobacter pylori eradication. Am J Gastroenterol 1994;89:1368 (abstract 333).
177. DalBo N, Ferrana M, Salandin S, et al. Azithromicin: A new useful therapeutic strategy for the eradication of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1368 (abstract 332).
178. Dettmer A. Double-blind comparative trial of ranitidine plus amoxicillin in patients with Helicobacter pylori positive duodenal ulcer. Am J Gastroenterol 1994;89:1369 (abstract 338).
179. Deltenre M, Jonas C, VanGossum M, et al. Omeprazole-amoxicillin and omeprazole-clarithromicin for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1369 (abstract 337).
180. Ferrini G, Larcinese G, Semperlotti N. Treatment with omeprazole and clarithromicin in duodenal ulcer associated with Helicobacter pylori. Am J Gastroenterol 1994;89:1370 (abstract 342).
181. Doppl WE, Waldherr M, Klor HU, et al. Low eradication rate of Helicobacter pylori after triple therapy. Am J Gastroenterol 1994;89: 1370 (abstract 340).
182. Fixa B, Komarkova O, Krejsek J, et al. Bismuth salts, amoxicillin and metronidazol in the treatment of Helicobacter pylori associated duodenal ulcer disease. Am J Gastroenterol 1994;89:1371 (abstract 344).
183. Grigoriev P, Klemashev I, Yakovenko A, et al. Comparative assessment of two medical methods of treatment in terms of remission duration of peptic ulcer disease associated with Helicobacter pylori. Am J Gastroenterol 1994;89:1372 (abstract 350).
184. Harris AW, Gummett PA, Logan RPH, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromicin. Am J Gastroenterol 1994;89:1373 (abstract 354).
185. Lerang F, Moum B, Ragnhildstveit E, et al. Alternative triple therapy for Helicobacter pylori-related peptic ulcer disease. Am J Gastroenterol 1994;89:1378 (abstract 371).
186. Maieron R, Avellini C, Scott CA, et al. Comparison between double and triple therapeutical modalities for Helicobacter pylori eradication. Am J Gastroenterol 1994;89:1380 (abstract 379).
187. Massarat S, Saberi-Firoozi M, Zare S, et al. Superiority of triple therapy over amoxicillin + tinidazol + omeprazole for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1380 (abstract 382).
188. Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: A predictor of failure to eradicate Helicobacter pylori by triple therapy. Am J Gastroenterol 1994;89:1382 (abstract 390).
189. Nebiki H, Arakawa T, Yamada H, et al. Absence of effect of eradication of Helicobacter pylori on gastric ulcer relapse, unlikely to duodenal ulcer. Am J Gastroenterol 1994;89:1383 (abstract 394).
190. Petrino R, DiNapoli A, Maccagno G, et al. Comparison of efficacy and tolerability of different management strategies for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1385 (abstract 400).
191. Schütze K, Hentschel E, Hirschl AM. Dose dependent effect of clarithromicin and ranitidine on eradication of Helicobacter pylori in patients with non ulcer dyspepsia. Am J Gastroenterol 1994;89:1387 (abstract 409).
192. Shimada T, Ogura K, Ota S, et al. PCR-evaluation of the lansoprazole-amoxicillin treatment for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1387 (abstract 410).
193. Shirai T, Tei Y, Takagi A, et al. Eradication of Helicobacter pylori lansoprazole + amoxicillin + plaunotol in duodenal ulcer. Am J Gastroenterol 1994;89:1388 (abstract 412).
194. Sjöstedt S, Mostafa MAM, Veress B, et al. Implications of acid suppression in Helicobacter pylori treatment. 24 h pH-monitoring and during treatment with omeprazole and amoxicillin. Am J Gastroenterol 1994;89:1388 (abstract 413).
195. Takimoto T, Taniguchi Y, Yoshida Y, et al. Combination therapy with lansoprazole and clarithromicin for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1389 (abstract 415).
196. Veldhuyzen van Zanten S, Hunt RH, Cockeram A, et al. Adding omeprazole 20 mg once a day to metronidazole/amoxicillin treatment of HP gastritis: A randomized double blind trial. The importance of metronidazole resistance. Am J Gastroenterol 1994;89:1389 (abstract 417)
197. Grigoriev PY, Zoseeva OV, Jakovenko AV, et al. Ranitidine antimicrobial therapy vs omeprazole-antimicrobial therapy for Helicobacter pylori-associated peptic ulcer. Am J Gastroenterol 1994;89:1392 (abstract 427).
198. Takats A, Racz I, Boga B, et al. Efficacy of a "one-day-triple therapy" with potentialisation of omeprazole for eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1399 (abstract 455).
199. Tyskiewicz T, Gerlee M, Wadström T. Lansoprazole/amoxicillin versus omeprazole/amoxicillin in Helicobacter pylori eradication. Am J Gastroenterol 1994;89:1400 (abstract 459).
200. Al-Assi MT, Karttunen T, Genta RM, et al. Successful, non-omeprazole-containing dual therapy for Helicobacter pylori infection: Clarithromicin-amoxicillin. Gastroenterology 1994;106(suppl):A38 (abstract).
201. Atherton JC, Cullen DJE, Hawkey CJ, et al. Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: Implications for mode of action. Gastroenterology 1994;106(suppl):A41 (abstract).
202. Atherton JC, Hawkey CJ, Spiller RC. Retreatment of Helicobacter pylori infection with amoxicillin and omeprazole in patients failing this regime is less successful than initial treatment. Gastroenterology 1994;106(suppl):A42 (abstract).
203. Borody TJ, Andrews P, Shortis NP, et al. Optimal Helicobacter pylori therapy: A combination of omeprazole and triple therapy. Gastroenterology 1994;106(suppl):A55 (abstract).
204. Chew K, Eidus L. Clarithromicin and high dose omeprazole for Helicobacter pylori eradication: A comparison of one and two week therapy. Gastroenterology 1994;106(suppl):A62 (abstract).
205. Connor BA. A short course of omeprazole, amoxicillin and metronidazole in the treatment of Helicobacter pylori infections. Gastroenterology 1994;106(suppl):A64 (abstract).
206. DeBona M, Bellumat A, Doglioni C, et al. Oral triple therapy for Helicobacter pylori eradication in dyspeptic patients. Gastroenterology 1994;106(suppl):A67 (abstract).
207. Ferulano GP, Dilillo S, Sabino N, et al. Omeprazole + amoxicillin vs. omeprazole + amoxicillin + metronidazole in the eradication of Helicobacter pylori. Gastroenterology 1994;106(suppl):A76 (abstract).
208. Forne M, Viver JM, Espinos JC, et al. Colloidal bismuth subcitrate is necessary in one week therapy with omeprazole and clarithromicin in the treatment of Helicobacter pylori-associated duodenal ulcer-randomized study. Gastroenterology 1994;106(suppl):A77 (abstract).
209. Gurbuz AK, Giardiello FM, Dagalp K, et al. Clarithromicin and omeprazole for Helicobacter pylori gastritis: An unsatisfactory regimen. Gastroenterology 1994;106(suppl):A85 (abstract).
210. Jonas C, DeKoster M, Depierreux, et al. Helicobacter pylori treatment: 10 days bismuth-omeprazole-clarithromicine capsules versus syrup. Gastroenterology 1994;106(suppl):A100 (abstract).
211. Katelaris PH, Patchett SE, Zhang ZW, et al. A randomised prospective comparison of omeprazole and clarithromicin versus omeprazole and amoxycillin for the eradication of Helicobacter pylori. Gastroenterology 1994;106(suppl):A104 (abstract).
212. Labenz J, Rühl GH, Bertrams J, et al. Re-treatment after failure of omeprazole plus amoxicillin to cure Helicobacter pylori infection in peptic ulcer disease. Gastroenterology 1994;106(suppl):A115 (abstract).
213. Neri M, Susi D, DiIorio P, et al. High-dose omeprazole with clarithromicin for one week: An effective dual therapy regimen for Helicobacter pylori infection. Gastroenterology 1994;106(suppl): A148 (abstract).
214. Saita H, Murakami M, Dekigai H, et al. Two weeks combination therapy with lansoprazole and amoxicillin for eradication of Helicobacter pylori. Gastroenterology 1994;106(suppl):A171 (abstract).
215. Zala G, Wirth HP, Giezendanner S, et al. Omeprazole/amoxicillin: Impaired eradication of Helicobacter pylori by smoking but not by omeprazole pretreatment. Gastroenterology 1994;106(suppl):A215 (abstract)
216. Catalano F, Rizzo G, AyoubiKhajekini MT, et al. Duodenal ulcer Helicobacter pylori positive: First results of the association with omeprazole and amoxicillin. Second United European Gastroenterology Week, Barcelona 1993;A100 (abstract).
217. DeMedici A, Sacca N, Rodino S, et al. Smoking does not have influence on the efficacy of omeprazole/amoxycillin combined therapy for eradication of Helicobacter pylori. Third United European Gastroenterology Week, Oslo 1994;A134:1439 (abstract).
218. Hatlebakk JG, Nesje LB, Hausken T, et al. Lansoprazol and amoxicillin oral suspension in the treatment of peptic ulcer disease. Third United European Gastroenterology Week, Oslo 1994;A137:1455 (abstract)
219. Jaspersen D, Koerner T, Schorr W, et al. Third United European Gastroenterology Week, Oslo 1994: A138, 1459 (abstract).
220. Pajares JM, Blanco M, Perez Miranda M, et al. Comparison of two triple therapies: Anti H2 or CBS plus two antibiotics to eradicate Helicobacter pylori and to prevent recurrence of duodenal ulcer. Third United European Gastroenterology Week, Oslo 1994;A144: 1488 (abstract).
221. Schütze K, Hentschel E, Hirschl AM. Ranitidine plus clarithromicin or amoxicillin in the treatment of Helicobacter pylori positive non ulcer dyspepsia. Third United European Gastroenterology Week, Oslo 1994;A148:1504 (abstract).
222. Utzon P, Aabakken L, Sandstad O, et al. Eradication of Helicobacter pylori with 10 or 14 days of bismuth triple regimes. Third United European Gastroenterology Week, Oslo 1994;A150:1516 (abstract).
223. Iser JH, Buttigieg RJ, Iseli A. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer. Med J Aust 1994;160:192-6.
224. Treiber G, Klotz U. Helicobacter pylori (HP) eradication rates do not depend on higher omeprazole plasma levels. Gastroenterology 1992; 102 (suppl):1389 (abstract 416).
225. Labenz J, Jorias I, Sollböhmer M, et al. 24-hour gastric pH pattern in patients with Helicobacter pylori-associated peptic ulcer disease treated with omeprazole 20 mg bid or 40 mg bid. Am J Gastroenterol 1994;89:1376 (abstract 365)
226. Labenz J, Leverkus F, Börsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori: Factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-75.
227. Villar J, Carroli G, Belizan JM. Predictive ability of meta-analyses of randomized controlled trials. Lancet 1995;345:772-6.